Omadacycline in Vitro Activity Against a Molecularly Characterized Collection of Clinical Isolates with Known Tetracycline Resistance Mechanisms

被引：0
|
作者：
不详
机构：
来源：
AMERICAN HEALTH AND DRUG BENEFITS | 2018年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：489 / 489
页数：1
相关论文
共 50 条
  • [31] Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes an other resistance mechanisms
    Castanheira, Mariana
    Deshpande, Lalitagauri M.
    Woosley, Leah N.
    Serio, Alisa W.
    Krause, Kevin M.
    Flamm, Robert K.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (12) : 3346 - 3354
  • [32] Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014)
    Duncan, Leonard R.
    Sader, Helio S.
    Smart, Jennifer I.
    Flamm, Robert K.
    Mendes, Rodrigo E.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2017, 10 : 271 - 276
  • [33] In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: activity is retained against isolates showing resistance to azoles and/or amphotericin B
    Escribano, Pilar
    Gomez, Ana
    Reigadas, Elena
    Munoz, Patricia
    Guinea, Jesus
    SPEIN Study Group
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (09) : 1291.e7 - 1291.e10
  • [34] In Vitro Activity of Ceftazidime-Avibactam against 338 Molecularly Characterized Gentamicin-Nonsusceptible Gram-Negative Clinical Isolates Obtained from Patients in Canadian Hospitals
    Denisuik, Andrew J.
    Karlowsky, James A.
    Denisuik, Tyler
    Nichols, Wright W.
    Keating, Thomas A.
    Adam, Heather J.
    Baxter, Melanie
    Walkty, Andrew
    Zhanel, George G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (06) : 3623 - 3626
  • [35] Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates
    Fritsche, TR
    Strabala, PA
    Sader, HS
    Dowzicky, MJ
    Jones, RN
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) : 209 - 213
  • [36] In Vitro Activity of Delafloxacin against Clinical Neisseria gonorrhoeae Isolates and Selection of Gonococcal Delafloxacin Resistance
    Soge, Olusegun O.
    Salipante, Stephen J.
    No, David
    Duffy, Erin
    Roberts, Marilyn C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) : 3106 - 3111
  • [37] In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms
    Arendrup, Maiken Cavling
    Jensen, Rasmus Hare
    Cuenca-Estrella, Manuel
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 532 - 536
  • [38] Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain:: in vitro activities of telithromycin and cethromycin
    Morosini, MI
    Cantón, R
    Loza, E
    del Campo, R
    Almaraz, F
    Baquero, F
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) : 50 - 55
  • [39] Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin -: Reply
    Griffiths, PD
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03)
  • [40] In Vitro Activity of Telavancin against a Contemporary Worldwide Collection of Staphylococcus aureus Isolates
    Mendes, Rodrigo E.
    Moet, Gary J.
    Janechek, Mike J.
    Jones, Ronald N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (06) : 2704 - 2706
12345